Celcius Launches Rs 500 Million Pharma Logistics Arm
WAREHOUSING & LOGISTICS

Celcius Launches Rs 500 Million Pharma Logistics Arm

Celcius Logistics, India’s leading tech-driven 3PL and cold supply chain provider, has launched Celcius+, a dedicated vertical for the seamless management of the pharmaceutical supply chain. The new arm is designed to meet the sector’s stringent demands for temperature control, compliance, and real-time visibility, ensuring safe and efficient transport of medicines, vaccines, and other sensitive products.
In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.
To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.
Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”
Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.
The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.
Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

Celcius Logistics, India’s leading tech-driven 3PL and cold supply chain provider, has launched Celcius+, a dedicated vertical for the seamless management of the pharmaceutical supply chain. The new arm is designed to meet the sector’s stringent demands for temperature control, compliance, and real-time visibility, ensuring safe and efficient transport of medicines, vaccines, and other sensitive products.In its first phase, the company will invest Rs 500 million to build a dedicated pharma fleet and supporting infrastructure, aiming to generate Rs 1 billion in annual recurring revenue (ARR) from this vertical within 18 months. Of this, Rs 350 million will be used to deploy 100 new reefer vehicles along key pharmaceutical corridors across India, while Rs 100–150 million is earmarked for developing a robust pharma courier system for high-demand urban and semi-urban markets.To drive this expansion, Celcius will hire 30–40 specialists in pharma logistics, operations, and compliance. Leveraging its advanced tech platform, Celcius+ will provide real-time tracking, continuous temperature monitoring, and AI-enabled route optimisation, ensuring shipments comply with the highest quality standards.Founder and CEO Swarup Bose said: “With Celcius+, we are expanding capacity while setting new benchmarks for safety, transparency, and operational excellence in pharma logistics. Our investment marks the start of a focused journey to reduce wastage, ensure compliance, and bridge gaps in pharma distribution with technology-driven solutions.”Celcius+ plans to partner with leading pharmaceutical companies and extend its reach to over 100 cities by the end of 2025. Its services will cover primary and secondary distribution, as well as last-mile pharma courier delivery for high-value products including vaccines, biologics, insulin, and specialty medicines.The 24-ft reefer fleet will be equipped with advanced telematics, digital lock systems, CCTV surveillance, and 24/7 tracking via a central control tower. This infrastructure is designed to guarantee product integrity and fast response to any disruptions.Earlier this year, Celcius Logistics raised Rs 2.5 billion in an oversubscribed Series B round to accelerate technology upgrades and network expansion. Currently operating across 600 cities, the company aims to scale to more than 1,000 cities in the coming years, with Celcius+ strengthening its presence in pharmaceutical logistics.

Next Story
Infrastructure Urban

Mount Invests Rs 250 Cr, Adds PUF & PEB Plants, 400+ Jobs

TUMKUR, Karnataka, January 8, 2025 - Mount Roofing & Structures Private Limited, one of India's  fastest-growing manufacturers in PUF and a leading solutions provider across Pre-Engineered Building  (PEB) and Polycarbonate sheets, simultaneously inaugurated its second fully automated continuous  Sandwich Panel manufacturing line and a new PEB manufacturing plant at its integrated campus in  Tumkur." The milestone expansion, part of a total investment of INR 250 crores, marks a significant  advancement in the company's commitment to engineered performance, manu..

Next Story
Infrastructure Urban

Titan Intech Strengthens UltraLED Push With Global LED Veteran

Titan Intech has announced the induction of global LED industry veteran Su Piow Ko to its Board of Directors, marking a strategic step in strengthening its UltraLED Displays roadmap and building globally competitive LED display solutions from India.The appointment aligns with Titan Intech’s ambition to position India as a hub for advanced, high-quality LED display manufacturing. With an increased focus on UltraLED Displays, the company aims to enhance technical governance, raise manufacturing standards and expand its presence across global markets.Su Piow Ko brings over three decades of inte..

Next Story
Infrastructure Urban

Dun & Bradstreet Flags New Growth Engines in India 2026 Outlook

Dun & Bradstreet has released its India 2026: D&B’s Perspective report, projecting a stable macroeconomic environment underpinned by fresh opportunities for productivity-led and inclusive growth. The report outlines how India’s next growth phase will be driven by digitised logistics, trusted data ecosystems, clean energy and rising city vitality.According to the outlook, India’s GDP growth is expected to reach around 6.6 per cent by FY2027, supported by resilient consumer demand and sustained public investment. Manufacturing is seen entering a new phase, moving beyond scale towar..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Open In App